ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025
COVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020-2021).
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundThe coronavirus disease 2019 (COVID-19) pandemic placed significant pressure on healthcare workers (HCWs) globally, exposing them to high risks of infection and psychological stress. This study assessed dynamic risks and protective factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among HCWs in Lima, Peru.
methodsWe conducted the Peru Healthcare Worker COVID Cohort (PHCWCC), a prospective cohort study during the pre-COVID-19 vaccination period (August 2020-May 2021) and the post-vaccination period (August 2021-May 2022). Data included weekly nasal swabs for SARS-CoV-2 testing, reports on exposures, symptoms, perceived risks, and vaccination status. Incidence and factors associated with SARS-CoV-2 positivity were analyzed.
resultsAmong 1369 HCWs, the infection rate increased from 1.15 (95% confidence interval [CI]: .90-1.14) to 1.71 (95% CI: 1.41-2.05) per 1000 HCW-days between the pre- and post-vaccination phases (P = .01). Despite 97% receiving the primary vaccine series and 75% a booster, perceived high infection risk rose from 26% to 35% (P < .001). Close contact with infected colleagues remained a consistent risk factor (odds ratio [OR] = 2.74, 95% CI: 1.85-4.05; P < .001). In the second phase, direct patient contact (OR = 1.92, 95% CI: 1.20-3.08; P = .006) and patient care environments (OR = 2.14, 95% CI: 1.35-3.40; P = .001) were linked to higher infection risk. Perceived infection risk was inversely associated with positivity (OR = 0.76, 95% CI: 0.63-0.91; P = .003).
conclusionsEvolving infection risks highlight the need for sustained infection prevention, including during non-patient care activities. Fostering risk awareness may reduce infection rates and strengthen healthcare system resilience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.